Bailey TS et al. Diabetes Obes Metab. 2016. doi: 10.1111/dom.12736.
Treatment duration 26 weeks
At 26 weeks, adults with type 2 diabetes who were inadequately controlled on sitagliptin + MET achieved:
*Starting dose at 0.6 mg/day with weekly dose escalation up to 1.8 mg/day.
†One subject was not exposed to the trial medication.
‡Baseline values for Victoza® + MET/sitagliptin + MET arm: A1C (%): 8.3/8.2; body weight (kg): 88.9/91.2.
A1C, glycated hemoglobin; BMI, body mass index; MET, metformin.
At 26 weeks, in adults with type 2 diabetes inadequately controlled on sitagliptin + MET: